Scarlet fever
scarlet fever streptococcal


Erythema marginatum may be seen in ~10% of cases — annular erythematous lesions that can recur over days to weeks.
| Route | Drug | Dose |
|---|---|---|
| Oral | Penicillin VK | Children <27 kg: 250 mg 2–3×/day × 10 days; Adults: 250 mg 4×/day or 500 mg 2×/day × 10 days |
| IM | Benzathine penicillin (Bicillin C-R) | <27 kg: 600,000 units once; ≥27 kg: 1,200,000 units once |
| Oral | Amoxicillin | Alternative first-line |
| Oral (PCN allergy) | Cephalexin or Clindamycin | Preferred penicillin-allergic alternatives |
| Oral (PCN allergy) | Erythromycin / macrolides | Option, but macrolide resistance in GAS is increasing |
| Condition | Key Distinguishing Features |
|---|---|
| Kawasaki disease | Prolonged fever >5 days, negative cultures, coronary artery aneurysm risk |
| SSSS | Bullae, superficial exfoliation, no pharyngitis |
| Toxic Shock Syndrome | Hypotension, multi-organ involvement |
| Drug hypersensitivity | Drug history, peripheral eosinophilia, less mucosal involvement |
| Staphylococcal scarlet fever | No pharyngitis, skin nidus |